agilon health (AGL)
NYSE Market Open
agilon health, inc. is a healthcare services company that works with primary care physician groups to deliver value-based care to senior patients, primarily through Medicare-focused arrangements. Rather than operating as a traditional insurer or hospital system, the company builds long-term partnerships with community-based doctors and supplies the infrastructure needed to manage patient populations under risk-bearing contracts.
Its model centers on helping physicians move from fee-for-service reimbursement toward arrangements in which care quality, patient outcomes, and total medical costs are closely linked. agilon provides technology, analytics, administrative support, payer contracting capabilities, and care-management tools that allow local practices to participate in capitated Medicare Advantage and other senior-care programs. This structure is intended to let physicians remain independent while gaining the scale and support required to coordinate care for older adults with complex medical needs.
The company’s platform is designed around primary care as the central point of the healthcare experience. By working with physicians who already have relationships in their communities, agilon seeks to improve preventive care, reduce avoidable hospital use, and manage chronic conditions more effectively. Its revenue and profitability are tied to membership growth, medical cost performance, contract terms with health plans, and the ability of partner practices to operate successfully in value-based care.
For investors, agilon represents exposure to the ongoing shift in U.S. healthcare reimbursement toward risk-based and outcomes-oriented models. Its distinctive position lies in serving as an enablement partner for independent primary care groups, with a specific focus on senior patients and Medicare-centric care delivery.
Last updated
- Market Cap
- 1.45B
- P/E
- —
- P/FCF
- —
- P/S
- 0.25
- Enterprise Value
- 1.34B
- Sector
- —
- Industry
- —
- Address
- 440 POLARIS PARKWAY, WESTERVILLE, OH, 43082
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 2, 2026 in agilon health, inc. Lawsuit – AGL
DEADLINE ALERT for AGL, FRMI, VRNS, and ARDT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
AGILON CLASS ACTION DEADLINE MARCH 2nd: Bragar Eagel & Squire, P.C. Urgently Reminds Agilon Health Investors with Large Losses to Contact the Firm Before the Lead Plaintiff Deadline
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm
AGILON DEADLINE MARCH 2nd: Bragar Eagel & Squire, P.C. Urgently Reminds Agilon Health Investors with Larges Losses to Contact the Firm Before the Lead Plaintiff Deadline
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGL
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM
ROSEN, THE FIRST FILING FIRM, Encourages Richtech Robotics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – RR
AGILON DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm
AGL DEADLINE NOTICE: agilon health, inc. Investors Encouraged to Contact Kirby McInerney LLP By March 2, 2026
DEADLINE ALERT for KLAR, AGL, FRMI: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
Robbins LLP Urges AGL Stockholders with Large Losses to Contact the Firm for Information About Leading the Agilon Health, Inc. Securities Class Action
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm
AGILON DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL
AGL SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026
DEADLINE ALERT for SLM, KLAR, AGL, FRMI: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
ROSEN, THE FIRST FILING FIRM, Encourages Richtech Robotics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – RR
Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 1.45B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 1.34B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 7.98
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.25
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -3.59
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.23
- EPS
- -21.25
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -62.54M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -195.41%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -23.56%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.17
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.98
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.98
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.11
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 510.91K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 86.75
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 1.42B | 1.57B | 1.44B | 1.39B | 1.53B |
| Gross profit | 65.02M | -90.67M | -67.65M | -52.43M | 50.72M |
| Operating income | 4M | -193.83M | -131.27M | -116.03M | -22.11M |
| EBITDA | 10.78M | -150.77M | -123.84M | -108.71M | -15.23M |
| Net income | 48.92M | -188.88M | -110.21M | -104.37M | 12.11M |
| Basic EPS | 2.95 | -11.5 | -6.75 | -6.25 | 0.73 |
| Diluted EPS | 2.94 | -11.5 | -6.75 | -6.25 | 0.73 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 1.5B | 1.27B | 1.6B | 1.71B | 1.93B |
| Total liabilities | 1.32B | 1.14B | 1.29B | 1.3B | 1.43B |
| Total equity | 181.43M | 126.73M | 306.08M | 408.93M | 500.25M |
| Cash & equivalents | 139.99M | 173.71M | 171.68M | 171.42M | 136.94M |
| Current assets | 1.25B | 1.1B | 1.34B | 1.45B | 1.65B |
| Current liabilities | 1.27B | 1.08B | 1.24B | 1.25B | 1.37B |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 23.73M | -20.54M | -18.15M | -35.09M | -31.99M |
| Investing cash flow | 19.27M | 22.58M | 18.66M | 70.46M | -23.09M |
| Financing cash flow | -5.15M | -17K | -236K | -2.58M | -161K |
| Change in cash | 37.85M | 2.03M | 268K | 32.79M | -55.24M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — agilon health, inc. | View Filing | |
| edgar index | SCHEDULE 13G — agilon health, inc. | View Filing | |
| edgar index | SCHEDULE 13G — agilon health, inc. | View Filing | |
| edgar index | 3 — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| form 4 | Form 4 — O'Rourke Timothy Patrick | View Filing | |
| form 4 | Form 4 — O'Rourke Timothy Patrick | View Filing | |
| edgar index | 8-K — agilon health, inc. | View Filing | |
| edgar index | 10-Q — agilon health, inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — agilon health, inc. | View Filing | |
| edgar index | DEFA14A — agilon health, inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEFA14A — agilon health, inc. | View Filing | |
| edgar index | ARS — agilon health, inc. | View Filing | |
| edgar index | DEF 14A — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| form 4 | Form 4 — Shaker Benjamin | View Filing | |
| form 4 | Form 4 — Gertsch Timothy | View Filing | |
| form 4 | Form 4 — Venkatachaliah Girish | View Filing | |
| form 4 | Form 4 — Zamore Denise | View Filing | |
| form 4 | Form 4 — Shaker Benjamin | View Filing | |
| form 4 | Form 4 — Gertsch Timothy | View Filing | |
| form 4 | Form 4 — Venkatachaliah Girish | View Filing | |
| form 4 | Form 4 — Zamore Denise | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| form 4 | Form 4 — Zamore Denise | View Filing | |
| form 4 | Form 4 — Zamore Denise | View Filing | |
| form 4 | Form 4 — Venkatachaliah Girish | View Filing | |
| form 4 | Form 4 — Venkatachaliah Girish | View Filing | |
| form 4 | Form 4 — Gertsch Timothy | View Filing | |
| form 4 | Form 4 — Gertsch Timothy | View Filing | |
| form 4 | Form 4 — Shaker Benjamin | View Filing | |
| form 4 | Form 4 — Shaker Benjamin | View Filing | |
| form 4 | Form 4 — Schwaneke Jeffrey A. | View Filing | |
| form 4 | Form 4 — Schwaneke Jeffrey A. | View Filing | |
| form 4 | Form 4 — Schwaneke Jeffrey A. | View Filing | |
| edgar index | 8-K — agilon health, inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — agilon health, inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| form 4 | Form 4 — Shaker Benjamin | View Filing | |
| form 4 | Form 4 — Shaker Benjamin | View Filing | |
| form 4 | Form 4 — Venkatachaliah Girish | View Filing | |
| form 4 | Form 4 — Venkatachaliah Girish | View Filing | |
| form 4 | Form 4 — Zamore Denise | View Filing | |
| form 4 | Form 4 — Zamore Denise | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| form 4 | Form 4 — Shaker Benjamin | View Filing | |
| edgar index | 8-K — agilon health, inc. | View Filing | |
| edgar index | 10-K — agilon health, inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | DEFA14A — agilon health, inc. | View Filing | |
| edgar index | DEF 14A — agilon health, inc. | View Filing | |
| edgar index | 8-K — agilon health, inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | PRE 14A — agilon health, inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| edgar index | 4 — agilon health, inc. | View Filing | |
| form 4 | Form 4 — Schwaneke Jeffrey A. | View Filing | |
| edgar index | 8-K — agilon health, inc. | View Filing |